Berkhamsted, United Kingdom

Sergio A Quezada

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sergio A Quezada

Introduction

Sergio A Quezada is a prominent inventor based in Berkhamsted, GB, known for his significant contributions to the field of cancer immunotherapy. With a total of 4 patents to his name, Quezada has made strides in developing innovative treatments that harness the body's immune system to combat cancer.

Latest Patents

Among his latest patents, Quezada has focused on combination immunotherapy for the treatment of cancer. His work involves agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor, such as CTLA-4 or PD-1. These innovations demonstrate potential effectiveness in treating tumors, showcasing his commitment to advancing cancer treatment methodologies.

Career Highlights

Throughout his career, Quezada has worked with esteemed institutions, including Memorial Sloan Kettering Cancer Center and the University of Texas System. His experience in these prestigious organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include James Patrick Allison and Padmanee Sharma, both of whom are recognized for their contributions to cancer research and immunotherapy. Their collaborations have further enhanced the impact of Quezada's work in the scientific community.

Conclusion

Sergio A Quezada's innovative work in cancer immunotherapy exemplifies the importance of research and collaboration in the fight against cancer. His patents and career achievements reflect a dedication to improving treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…